Apr 17, 2024

There’s a lot of research around Type 2 diabetes that has informed patient care when it comes to diagnosis, treatment, and lifestyle management. But much less is known about Type 1, long mislabeled “childhood diabetes.” Johns Hopkins epidemiologists Elizabeth Selvin and Michael Fang talk with Stephanie Desmon...

Apr 3, 2024

Xolair is the first FDA-approved therapy to prevent severe and potentially life-threatening reactions in adults and children who are allergic to dairy, eggs, wheat, nuts and other foods. Dr. Robert Wood, the director of pediatric allergy and immunology at Johns Hopkins, talks with Lindsay Smith Rogers about this drug...

Mar 27, 2024

Despite a national plan to eliminate syphilis by 2010, the sexually transmitted infection has reached the highest rates since the 1950s. Dr. Khalil Ghanem, a researcher of sexually transmitted infections at the Johns Hopkins Bloomberg School of Public Health, talks with Stephanie Desmon about syphilis infections and...

Mar 20, 2024

Menopause: inevitable, stigmatized, mysterious, and bringing a broad range of symptoms and experiences. Dr. Martha Hickey, a menopause researcher at the University of Melbourne, talks with Stephanie Desmon about a new Lancet series on menopause. They discuss how ageism and sexism come into play, the vast array of...

Feb 28, 2024

Imagine going to the pharmacy to buy a needed medicine and then finding out you purchased a falsified product that was, at best, ineffective, but at worst contained something toxic or deadly? This is the unfortunate reality in many places worldwide. Dr. Murray Lumpkin, who leads global regulatory systems for the Bill &...